Repligen (NASDAQ:RGEN) Releases FY23 Earnings Guidance kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Repligen (NASDAQ:RGEN – Free Report) had its price objective lifted by Royal Bank of Canada from $157.00 to $195.00 in a research report sent to investors on Thursday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the biotechnology company’s stock. Several other research analysts have also recently issued reports on […]
Repligen (NASDAQ:RGEN) Issues Earnings Results theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Repligen (NASDAQ:RGEN) Posts Quarterly Earnings Results, Beats Estimates By $0 04 EPS themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Repligen (NASDAQ:RGEN – Get Free Report) announced its quarterly earnings data on Wednesday. The biotechnology company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.49 by $0.04, Briefing.com reports. The firm had revenue of $159.20 million for the quarter, compared to the consensus estimate of $165.93 million. Repligen had a net margin […]